T1	Participants 65 113	737 patients with aggressive malignant lymphoma.
T2	Participants 115 201	From July 1984 to September 1987, 737 patients with aggressive malignant lymphoma (ML)
T3	Participants 656 687	Four hundred forty-two patients
